According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are C$0.13 Billion. In 2025 the company made an earning of C$40.73 Million, an increase over its 2024 earnings that were of C$34.17 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.